"Manitoba health-care providers are being advised to stop using a certain influenza vaccine after three people from New Brunswick reported neurologic symptoms including numbness or weakness of the face or limbs.
The Flulaval Tetra (KX9F7) shot, manufactured by GlaxoSmithKline Inc. (GSK), learned of the effects on Nov. 13.
“Patient safety is a top priority for GSK,” the company said in a statement. “On Friday, November 13, we learned of the 3 reported serious adverse events in New Brunswick, Canada. We have launched our own internal investigations and are currently working with the Canadian health authorities to obtain more information as part of those investigations."
- WINNIPEG CTV
コメント